247 related articles for article (PubMed ID: 24213150)
1. Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.
Jeong DC; Chung NG; Cho B; Zou Y; Ruan M; Takahashi Y; Muramatsu H; Ohara A; Kosaka Y; Yang W; Kim HK; Zhu X; Kojima S
Haematologica; 2014 Apr; 99(4):664-71. PubMed ID: 24213150
[TBL] [Abstract][Full Text] [Related]
2. Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study.
Atta EH; Dias DS; Marra VL; de Azevedo AM
Ann Hematol; 2010 Sep; 89(9):851-9. PubMed ID: 20373101
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
[TBL] [Abstract][Full Text] [Related]
4. Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A.
Garanito MP; Carneiro JD; Odone Filho V; Scheinberg P
J Pediatr (Rio J); 2014; 90(5):523-7. PubMed ID: 24878006
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.
Hayakawa J; Kanda J; Akahoshi Y; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Yamazaki R; Kako S; Kanda Y
Int J Hematol; 2017 May; 105(5):578-586. PubMed ID: 28078653
[TBL] [Abstract][Full Text] [Related]
6. Comparison of outcomes of immunosuppressive therapy with rabbit versus horse antithymocyte globulin and cyclosporine a in children with acquired severe aplastic anemia.
Yoshimi A; Noellke P; Starý J; Kállay K; Smith O; Locatelli F; Buechner J; Bodova I; Sevilla J; Schmugge M; Bierings M; Masmas T; Dworzak M; Labarque V; Pawelec K; Jahnukainen K; Polychronopoulou S; Kjollerstrom P; Kavcic M; Erlacher M; Niemeyer CM; Strahm B
Am J Hematol; 2024 Jul; 99(7):1403-1406. PubMed ID: 38622880
[No Abstract] [Full Text] [Related]
7. Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
Atta EH; Lima CBL; Dias DSP; Clé DV; Bonduel MM; Sciuccati GB; Medeiros LA; Oliveira MM; Salvino MA; Garanito MP; Blum Fonseca PB; Saad STO; Calado RT; Scheinberg P
Ann Hematol; 2017 Nov; 96(11):1907-1914. PubMed ID: 28815305
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.
Afable MG; Shaik M; Sugimoto Y; Elson P; Clemente M; Makishima H; Sekeres MA; Lichtin A; Advani A; Kalaycio M; Tiu RV; O'Keefe CL; Maciejewski JP
Haematologica; 2011 Sep; 96(9):1269-75. PubMed ID: 21606164
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine.
Lan Y; Chang L; Yi M; Cai Y; Feng J; Ren Y; Liu C; Chen X; Wang S; Guo Y; Zhang A; Liu L; Zhang J; Zhu X
Ann Hematol; 2021 Jan; 100(1):53-61. PubMed ID: 33033910
[TBL] [Abstract][Full Text] [Related]
10. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.
Kekre N; Zhang Y; Zhang MJ; Carreras J; Ahmed P; Anderlini P; Atta EH; Ayas M; Boelens JJ; Bonfim C; Deeg HJ; Kapoor N; Lee JW; Nakamura R; Pulsipher MA; Eapen M; Antin JH
Haematologica; 2017 Jul; 102(7):1291-1298. PubMed ID: 28341733
[TBL] [Abstract][Full Text] [Related]
11. Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.
Yoshimi A; van den Heuvel-Eibrink MM; Baumann I; Schwarz S; Simonitsch-Klupp I; de Paepe P; Campr V; Kerndrup GB; O'Sullivan M; Devito R; Leguit R; Hernandez M; Dworzak M; de Moerloose B; Stary J; Hasle H; Smith OP; Zecca M; Catala A; Schmugge M; Locatelli F; Führer M; Fischer A; Guderle A; Nöllke P; Strahm B; Niemeyer CM
Haematologica; 2014 Apr; 99(4):656-63. PubMed ID: 24162791
[TBL] [Abstract][Full Text] [Related]
12. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
[TBL] [Abstract][Full Text] [Related]
13. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia.
Scheinberg P; Nunez O; Weinstein B; Scheinberg P; Biancotto A; Wu CO; Young NS
N Engl J Med; 2011 Aug; 365(5):430-8. PubMed ID: 21812672
[TBL] [Abstract][Full Text] [Related]
14. In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia.
Feng X; Scheinberg P; Biancotto A; Rios O; Donaldson S; Wu C; Zheng H; Sato K; Townsley DM; McCoy JP; Young NS
Haematologica; 2014 Sep; 99(9):1433-40. PubMed ID: 24907357
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party.
Marsh JC; Bacigalupo A; Schrezenmeier H; Tichelli A; Risitano AM; Passweg JR; Killick SB; Warren AJ; Foukaneli T; Aljurf M; Al-Zahrani HA; Höchsmann B; Schafhausen P; Roth A; Franzke A; Brummendorf TH; Dufour C; Oneto R; Sedgwick P; Barrois A; Kordasti S; Elebute MO; Mufti GJ; Socie G;
Blood; 2012 Jun; 119(23):5391-6. PubMed ID: 22544699
[TBL] [Abstract][Full Text] [Related]
16. Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.
Kamio T; Ito E; Ohara A; Kosaka Y; Tsuchida M; Yagasaki H; Mugishima H; Yabe H; Morimoto A; Ohga S; Muramatsu H; Hama A; Kaneko T; Nagasawa M; Kikuta A; Osugi Y; Bessho F; Nakahata T; Tsukimoto I; Kojima S;
Haematologica; 2011 Jun; 96(6):814-9. PubMed ID: 21422115
[TBL] [Abstract][Full Text] [Related]
17. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
Clé DV; Atta EH; Dias DSP; Lima CBL; Bonduel M; Sciuccati G; Medeiros LA; de Oliveira MM; Blum Fonseca PB; Saad STO; Hamerschlak N; Salvino MA; Garanito MP; Pazin-Filho A; Scheinberg P; Calado RT
Ann Hematol; 2018 Nov; 97(11):2039-2046. PubMed ID: 29978284
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine.
Nishikawa E; Yagasaki H; Hama A; Yabe H; Ohara A; Kosaka Y; Kudo K; Kobayashi R; Ohga S; Morimoto A; Watanabe KI; Yoshida N; Muramatsu H; Takahashi Y; Kojima S
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27808465
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia.
Chen M; Liu C; Zhuang J; Zou N; Xu Y; Zhang W; Li J; Duan M; Zhu T; Cai H; Cao X; Wang S; Zhou D; Han B
Eur J Haematol; 2016 Mar; 96(3):291-6. PubMed ID: 25996247
[TBL] [Abstract][Full Text] [Related]
20. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
